Agonistic and antagonistic targeting of immune checkpoint molecules differentially regulate osteoclastogenesis

INTRODUCTION: Immune checkpoint inhibitors are used in the treatment of various cancers and have been extensively researched with regard to inflammatory and autoimmune diseases. However, this revolutionary therapeutic strategy often provokes critical auto-inflammatory adverse events, such as inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Brom, Victoria C., Strauss, Andreas C., Sieberath, Alexander, Salber, Jochen, Burger, Christof, Wirtz, Dieter C., Schildberg, Frank A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931766/
https://www.ncbi.nlm.nih.gov/pubmed/36817431
http://dx.doi.org/10.3389/fimmu.2023.988365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931766/
https://www.ncbi.nlm.nih.gov/pubmed/36817431
http://dx.doi.org/10.3389/fimmu.2023.988365

Ejemplares similares